Evolus GAAP EPS of -$0.30 misses by $0.05, revenue of $68.5M misses by $3.94M
Source: SeekingAlpha
2025-05-07 16:10:50 ET
More on Evolus
- Evolus: Two-Product Aesthetics Company With A Competitive Edge
- Evolus, Inc. 2024 Q4 - Results - Earnings Call Presentation
- Evolus, Inc. (EOLS) Q4 2024 Earnings Call Transcript
- Evolus announces commercial launch of Evolysse
- Seeking Alpha’s Quant Rating on Evolus
Read the full article on Seeking Alpha
For further details see:
Evolus GAAP EPS of -$0.30 misses by $0.05, revenue of $68.5M misses by $3.94M
Evolus Inc.
NASDAQ: EOLS
EOLS Trading
6.39% G/L:
$5.16 Last:
322,777 Volume:
$5.02 Open:
EOLS Latest News
EOLS Stock Data
$288,448,039
43,258,131
1.1%
49
N/A
Pharmaceuticals
Healthcare
US
Newport Beach
